Boletín 39 - Segundo cuatrimestre 2014

Detalles

Boletín 39. Segundo cuatrimestre de 2014.

 

NOTICIAS

 

CATs

Estrógenos exógenos en mujeres con enfermedad mental severa (Mª José Aguilera Moreno, Melodía López Romero y María González López, Agosto de 2014)

Efectividad de los grupos de autoayuda en salud mental (Carmen Pérez García, Julio 2014)

Terapia cognitivo-conductual y farmacoterapia en el insomnio (Gema Ruiz Guerrero, Mª del Carmen Rosado García y Eva Utrera Caballero, Junio de 2014)

Eficacia de la desvenlafaxina en pacientes con esquizofrenia (Cristina Corbalán Guerrero, Junio de 2014)

Antidepresivos para la mejora sintomática en pacientes con fibromialgia (Belén Mª Martínez Moro, Junio 2014)

Eficacia de la Terapia Cognitivo Conductual en la Anorexia Nerviosa ( Eva Utrera Caballero, Mª del Carmen Rosado García, Gema Ruiz Guerrero y José Antonio Ariza Coto, Junio de 2014)

Relación entre el consumo de cannabis y la aparición un primer episodio psicótico (Belén Mª Martínez Moro, Junio 2014)

Eficacia de la Terapia Electroconvulsiva en pacientes con Esquizofrenia (Eficacia de la Terapia Electroconvulsiva en pacientes con Esquizofrenia, Junio de 2014)

Influencia de la clozapina en el aumento del peso corporal de las personas en tratamiento (Eva Utrera Caballero, Mª del Carmen Rosado García, Gema Ruiz Guerrero y José Antonio Ariza Coto, Junio de 2014)

Relación entre la emoción expresada y el desarrollo de un trastorno límite de la personalidad (Servicio de Atención al Profesional, Mayo de 2014)

 

GUÍAS DE PRÁCTICA CLÍNICA

En este link se pueden consultar las publicaciones y contenidos de Guías de Práctica Clínica (link).

 

NUEVAS EVIDENCIAS

Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar 1;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. (Original) PMID: 24480899

Singh JP, Fazel S, Gueorguieva R, et al. Rates of violence in patients classified as high risk by structured risk assessment instruments. Br J Psychiatry. 2014 Mar;204(3):180-7. doi: 10.1192/bjp.bp.113.131938. (Review) PMID: 24590974

Freeman J, Sapyta J, Garcia A, et al. Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)--a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):689-98. doi: 10.1001/jamapsychiatry.2014.170. (Original) PMID: 24759852

Miller M, Swanson SA, Azrael D, et al. Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med. 2014 Jun;174(6):899-909. doi: 10.1001/jamainternmed.2014.1053. (Original) PMID: 24782035

McEvoy JP, Byerly M, Hamer RM, et al. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA. 2014 May 21;311(19):1978-87. doi: 10.1001/jama.2014.4310.(Original) PMID: 24846035

Wiles N, Thomas L, Abel A, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014 May;18(31):1-167, vii-viii. doi: 10.3310/hta18310. (Original) PMID: 24824481

Mahapatra J, Quraishi SN, David A, et al. Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders. Cochrane Database Syst Rev. 2014 Jun 10;6:CD001470. doi: 10.1002/14651858.CD001470.pub2. (Review) PMID: 24915451

Chien WT, Thompson DR. Effects of a mindfulness-based psychoeducation programme for Chinese patients with schizophrenia: 2-year follow-up. Br J Psychiatry. 2014 Jul;205(1):52-9. doi: 10.1192/bjp.bp.113.134635. Epub 2014 May 8.(Original) PMID: 24809397

Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828. (Original) PMID: 24941178

Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;7:CD004687. doi: 10.1002/14651858.CD004687.pub4. (Review) PMID: 24984083

Tardy M, Huhn M, Kissling W, et al. Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2014 Jul 9;7:CD009268. doi: 10.1002/14651858.CD009268.pub2. (Review) PMID: 25007358

Tardy M, Dold M, Engel RR, et al. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2014 Jul 8;7:CD009396. doi: 10.1002/14651858.CD009396.pub2. (Review) PMID: 25003310

Amos T, Stein DJ, Ipser JC. Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2014 Jul 8;7:CD006239. doi: 10.1002/14651858.CD006239.pub2. (Review) PMID: 25001071

Craig T, Shepherd G, Rinaldi M, et al. Vocational rehabilitation in early psychosis: cluster randomised trial. Br J Psychiatry. 2014 May 22. pii: bjp.bp.113.136283. (Original) PMID: 24855129

Fleischhacker WW, Sanchez R, Perry PP, et al. Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study. Br J Psychiatry. 2014 Jun 12. pii: bjp.bp.113.134213. (Original) PMID: 24925984

Tardy M, Huhn M, Engel RR, et al. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2014 Aug 3;8:CD009230. (Review) PMID: 25087165

Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014 Jul 2;312(1):78-84. doi: 10.1001/jama.2014.5950. (Review) PMID: 25058220

McDonagh M, Matthews A, Phillipi C, et al. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period. Evidence Report/Technology Assessment No. 216. Evid Rep Technol Assess (Full Rep). 2014 July;(216):1-308. (Review) Texto completo.